research

health

Sotera Health Co

action

$SHC all of the other pharm stocks that received bad news recently tanked 40%-60% and this fuccca is up 100% get the fucc out of here damnit this is manipulation and abuse of the shareholders and we should take legal action on these fuccers.

cancer

$SHC SHC SHC, let me see; how terrible a stock thy may be - no bird, no bee, they&#39;re dead because of thee, along with your friends and family getting cancer.

$SHC member when a company that was supposed to help people with good health; actually just gave them cancer?

There can&#39;t be any serious bulls here, how could you possibly justify putting your money into a company in the midst of settling lawsuits for giving people cancer

$SHC they also owe this grandma $363 Million for giving her cancer. Scumbags.

$SHC many people got cancer because of this dirty corp. money does not equal life

$SHC this is pure manipulation 400M and counting lawsuit for KILLING and giving people CANCER!!!!!!!.

Their services has caused cancer and killed people across US.

trading

From the current trading price; there is significant downside

Never enjoyed trading em or made money of em - and pharma is highly unethical and immoral as is and proven time and time again.

cash

$SHC this stock price is way overvalued; and is currently unable to meet their debt obligations; effectively making the company insolvent.

Probably better to shut this company down and liquidate the assets to pay the debt, and make sure no one else is killed by this company.

$SHC Too many red flags to stay in (high $1B debt, poor cash flow, new $400M obligation).

Not only do they not have enough cash for what they’ve agreed to pay, it is likely they’ll have to pay more.

$SHC I dont understand the share price the finances are real bad the amount of debt is mind boggling

Debt to equity ratio -3 very dangerous to invest.

company

The company essentially lied in their JP Morgan corporate presentation when they indicated their leverage would continue a “-54%” leverage decrease through September 2022.

$SHC $Sotera Health Co  whose still buying this bs 
Let it drop all ready we all know this company is trash

$SHC me personally, if I were an insider in this shit company I wouldve dumped all my shares on 100% pump

People dying because of this company lol why would one buy this crap

Sotera Health upgraded by Wolfe Research to outperform.

Sotera Health Co The statistical model has detected the value of this company has a strongly positive short term outlook and will be followed by a solid upmove in the coming months $SHC

$SHC Sotera Health Co Our model is forecasting this equity value will substancially appreciate shortly and has really supportive long term fundamentals

offering

$SHC 400M lawsuit and when the offering comes they will say its unbelievable

$SHC  HUSA🇺🇸 gonna be the next tinyfloat Mega runner in 2023🚀🚀 💯               
Best thing about HUSA is they can’t file anymore S-3 for offering and needs shareholders approval for any new one💠

$SHC  HUSA🇺🇸 gonna be the next tinyfloat Mega runner in 2023🚀🚀💯              
Best thing about HUSA is they can’t file anymore S-3 for offering and needs shareholders approval for any new one 💠

$SHC  HUSA🇺🇸 gonna be the next tiny float Mega runner in 2023 🚀🚀 💯             
Best thing about HUSA is they can’t file anymore S-3 for offering and needs shareholders approval for any new one 💠

$SHC  HUSA🇺🇸 gonna be the next tiny float Mega runner in 2023 🚀🚀 💯             
Best thing about HUSA is they can’t file anymore S-3 for offering and needs shareholders approval for any new one 💪

approval

bullish

$SHC Bullish reversal setup here now. flying.

$SHC Bullish setup here, watching big upside candle here.

Anavex Life Sciences Corporation

wait

Seems crazy to me to unjust approvals that are going on while we wait on legitimate results!!!

But why wait 3 years with that when Anavex 50mg dose is likely better! !

So, if one waits months for an answer and then has to resubmit to another journal it can hold things up.

This is a shitshow till data is presented.

loss

but  losses  and  disappointment  with  Missling.

$AVXL Took my $250 loss and Got out guys too much noise not enough action.

but was faked by the move and held them to expiration and had to book a loss of $19,000.

shareholder

The krout has proven to be an a hole toward shareholders.

Missling is a greedy pig, doesnt see the bad he does by delaying intentionally, not only to shareholders,

i am telling for years that we need to fire that shitty guy just here to full his pockets without any consideration for his shareholders.

.this guy doesnt respect his shareholders and he must be sue for that.

$AVXL fire Missling, he has been here 9 years and done nothing to drive shareholder value other than BS hype

$AVXL why does the company not believe they are beholden to their shareholders?

$AVXL Unfortunately the Investorshub AVXL board has deteriorated to the point that it is basically a board consisting of almost entirely FUD with almost more bashers than true shareholders.

Messling is grossly deficient in anticipating the expectations of shareholders and the market.

$AVXL as corporate shareholder, I have sent an email on dec. 21st and a friendly reminder yesterday to IR - no response yet !!

One hand he says he care for shareholder value, on other hand he is purposely not sharing updates.

shareprice

$AVXL missling next time should change a few letters when hiring and SP will improve: from FDA to FBI former employee.

$AVXL Every time Missling speaks, the SP tanks…..amateurish communication, unbelievable.

It&#39;s stupid, it wastes time (and $$$) and it leaves the company vulnerable with a supressed SP.

Based on Rett alone, SP is well under 100$, sorry to bust your ballown,but please try to stay realist and keep a little credibility!

$AVXL The sp is wrong there must be a glitch

$AVXL not that i am happy with the SP overall

$AVXL Until you realize that and admit that the presenter screwed up in rushing the presentation the SP will stay where it’s at

$AVXL wandering when we will cross ANVS SP ;) 
never again!!!!

$AVXL we didnt cross ANVS SP yet, no good haha!

show

Take your money from this shit show and deposit in your bank account.

What an absolute unregulated criminal shit show this market has become.

Missling shows poor judgement and is not suited to be ceo.

SHOWS THE EXTREME WEAKNESS AND  DISTRESS THE STOCK IS UNDER.

but need more time to evaluate and announce a conference call for Monday instead we have a shit show.

I made good profits on Friday and have left profits in stock in support of the research.

Also like the fact that the drug intervenes in tau blocking as that is also a target in AD research.

Research would show there is a significant chance of awesome results here,

Brilliant because the government in Australia recognizes the value of research and grants 43.5% return on each dollar spent.

Here’s to prosperity, good health and family/friends and creating a better world thru scientific innovation🧠🎆🫶

$cosm 

“Greg Siokas, Chief Executive Officer of Cosmos Health stated, &quot;I am excited to see Cosmos emerge in to in a stronger financial position.

business-result

Anavex&#39;s A2-73 Blarcamesine&#39;s trial results on 2 previously completed adult phase-3 trials were highly successful.

But the company actually has never seen before wonderful results.

If results hold up, the stock will achieve massive gains.

The results were excellent on the 2 completed adult trials, and because the 3rd trial is pediatric and early on the disease, they are expected to perform even better.

Alzheimer&#39;s is the most valuable and most difficult indication and most desired lately..  and only Anavex really has some great results with a great safety record. .

The  sava  results  trounce  you  guys  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

Sava has potential and the phase 3 results will show the truth.

drug

- Timo grimmer is in the team 
- All endpoints of the clinical trial were reached 
 
I firmly believe that the drug works and that the CEO has done a good job no matter how much he is criticized.

we have a drug, even many drugs, good for so many indications,  to become a giant pharma, we are about to get billions in revenues.

$AVXL The improvements in the drug arm cannot be lucky. .

I&#39;m looking forward to seeing the long term AD data on ANVS and have the feeling it&#39;s going to end up being the best in class AD treatment as well.

Do not listen to any FUD this drug is the real deal.

$AVXL amazing to see the actual benefits to people and their families of this “miracle drug” as they call it

$AVXL Dr. Perry said we have a legendary drug which actually reverses AD and is safe unlike Adulhelm.

trial

$AVXL amazing  avxl  still  in  singke  digits  after  a  supposedly  amazing  “pivotal”  trial  readout  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

$AVXL The trial met both co-primary and secondary endpoints showing statistically significant reduction of clinical decline as measured by those endpoints.

$AVXL Australia trial data meets the gold standard.

2-73 has orphan designation for Rett which combined with the multiple Rett trials and it very good safety record should make it a great candidate for AA.

This company has yet to fail to meet endpoints on any trial and the thousands of papers on the MOA  eliminates fraud with science, and the company is in great fiscal shape so no shenanigans there.

Movano Inc

The women’s health market is on fire right now and Evie is in the right place at the right time.

They are thoughtful, passionate and smart about bringing Evie to market and evangelizing for women’s health.

$MOVE Excited to see Movano’s talented team of women evangelizing for women’s health ahead of their early ‘23 launch of their ring .

$RKLY and $MOVE 
2 companies that could be the future of Health and Wellness.

move

$MOVE putting in a nice monthly topping candle so far

$MOVE Lots of good stuff in Movano&#39;s PR today.

$MOVE https://youtu.be/RTNidZ71lu8 
3 days ago, pretty interesting

$MOVE Still have not missed on their timeline or milestones.

$MOVE Time to buy more, now that MOVE is funded for the rollout of Evie.

$MOVE $RKLY 
Both of these companies stand at the forefront of affordable non-invasive diagnostics.

Both companies have tech that can go well beyond current optical sensors.

Top Stocks matching your search for "research health"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

SHC

Sotera Health Co

-0.67%

$17.85 - $17.73

Jan, 11, 2023

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Dec, 5, 2022

Nov, 19, 2022

MOVE

Movano Inc

-7.86%

$1.40 - $1.29

SHC

Sotera Health Co

-0.67%

$17.85 - $17.73

Jan, 11, 2023

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Dec, 5, 2022

Nov, 19, 2022

Nov, 7, 2022

Oct, 26, 2022

MOVE

Movano Inc

-7.86%

$1.40 - $1.29